Macrobid and Acarodermatitis - a phase IV clinical study of FDA data

Summary:

Acarodermatitis is reported as a side effect among people who take Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Celebrex, and have Cellulitis.

The phase IV clinical study analyzes which people have Acarodermatitis when taking Macrobid. It is created by eHealthMe based on reports of 8,335 people who have side effects when taking Macrobid from the FDA, and is updated regularly.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 9,215 Macrobid users. Check the latest studies of Macrobid.

What is Acarodermatitis?

Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 250 drugs and 307 conditions by eHealthMe. Check the latest studies of Acarodermatitis.

On Jan, 01, 2026

8,335 people reported to have side effects when taking Macrobid.
Among them, 14 people (0.17%) have Acarodermatitis.

Among these 14 people:

How long have people been on Macrobid when they have Acarodermatitis? *

What is the gender of people who have Acarodermatitis when taking Macrobid? *

female: 100 %
male: 0.0 %

What is the age of people who have Acarodermatitis when taking Macrobid? *

What are other drugs people take besides Macrobid? *

What are other side effects people have besides Acarodermatitis? *

White Blood Cells Urine Positive: 14 people, 100.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 14 people, 100.00%
Pain: 14 people, 100.00%
Oral Herpes (viral infection of mouth): 14 people, 100.00%
Nausea (feeling of having an urge to vomit): 14 people, 100.00%
Nasopharyngitis (inflammation of the nasopharynx): 14 people, 100.00%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 14 people, 100.00%
Weight Increased: 14 people, 100.00%
Joint Range Of Motion Decreased (disease of joint movement): 14 people, 100.00%
Pericarditis (inflammation of the pericardium): 14 people, 100.00%

What are the existing conditions these people have? *

Cellulitis (infection under the skin): 13 people, 92.86%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 10 people, 71.43%
Still's Disease Adult Onset (a rare illness that causes high fevers, rash, and joint pain in adult just started): 4 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Macrobid and have Acarodermatitis?

- Check whether Acarodermatitis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Macrobid:

Macrobid (9,215 reports)

Acarodermatitis treatments and more:

Acarodermatitis (2,497 reports)

How severe was Acarodermatitis and when was it recovered:

Acarodermatitis in Macrobid

Expand to all the drugs that have ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline:

Acarodermatitis and drugs with ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acarodermatitis:

Acarodermatitis (250 drugs)

Browse all the conditions that are associated with Acarodermatitis:

Acarodermatitis (307 conditions)

Drugs similar to Macrobid and Acarodermatitis :

How the study uses the data?

The study uses data from the FDA. It is based on nitrofurantoin; nitrofurantoin, macrocrystalline (the active ingredients of Macrobid) and Macrobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.